Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | Doxorubicin hydrochloride lipid nanoparticles |
| Catalog Number | LNP-002 |
| Size | 10 mg; 20 mg; 50 mg |
| Alias | Doxorubicin hydrochloride-loaded lipid nanoparticles; Doxorubicin encapsulated lipid vesicles |
| Appearance | Dark red transparent or slightly opalescent uniform liquid |
| Solubility | It is a hydrocolloid dispersible injection that can be directly diluted with normal saline or 5% glucose injection. |
| Description | Doxorubicin hydrochloride-loaded lipid nanoparticles is a PEGylated long-circulation lipid nanoparticle injection that uses advanced nanotechnology to encapsulate doxorubicin hydrochloride. It is a model of the third generation of lipid nanoparticle anticancer agents. Its prescription is based on long-circulation lipid nanoparticle technology (usually using HSPC/chol/DSPE-mPEG2000 or similar components). |
| Applications | Control standards for nanomedicine pharmacokinetics and biodistribution studies |
| Storage | 4°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 Year |
| Shipping Condition | Low temperature transport |